Today, cancer is no longer solely defined by location or even by stage. We know there is no routine cancer, and there is no routine bone cancer, or sarcoma.
Bone cancer is a complex disease. Each patient’s disease is different, behaving differently in the bodies they’re in and calling for a tailored, individualized treatment plan for each patient.
To deliver the most effective bone cancer detection and treatment, our nationally renowned experts identify and understand cancer at the biologic and genetic levels, unlocking the molecular code of a patient’s disease and pinpointing what makes each cancer grow – then discovering what stops it.
Our team of bone cancer sub-specialists spans a broad range of disciplines: from medical, surgical and radiation oncologists to molecular and biological pathologists, orthopedic oncologists to genetic scientists and more – all specializing in bone cancer (and only bone cancer) research, prevention, detection, treatment and cure.
In addition, the OSUCCC – James has the most comprehensive and specialized team in the country, including multiple medical and surgical disciplines to manage and treat large extremity, pelvic and spine regional soft tissue cancers.
It’s that sub-specialization and singular focus that enables us to discover, develop and deliver the most targeted therapies for each individual bone cancer patient.
And that means our collective expertise leads to improved outcomes, faster responses, fewer side effects and more hope for cancer patients everywhere.